Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oxidation-Reduction Reactions03:11

Oxidation-Reduction Reactions

75.2K
Oxidation–Reduction Reactions
75.2K
Block Diagram Reduction01:22

Block Diagram Reduction

545
The process of deriving the transfer function of a control system often involves reducing its block diagram to a single block. This simplification can be achieved through a series of strategic operations, including relocating branch points and comparators. These operations preserve the overall function of the system while allowing for easier manipulation and combination of blocks.
The first step in this process is the identification and relocation of a branch point. A branch point, where a...
545
Oxymercuration-Reduction of Alkenes02:36

Oxymercuration-Reduction of Alkenes

9.3K
Oxymercuration–reduction of alkenes is one of the major reactions converting alkenes to alcohols. It involves the hydration of alkenes with mercuric acetate in a mixture of tetrahydrofuran and water, forming an organomercury adduct. This is followed by a demercuration step in which the adduct is reduced to an alcohol using sodium borohydride.
9.3K
Phase I Reactions: Reductive Reactions01:27

Phase I Reactions: Reductive Reactions

584
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
584
Esters to Alcohols: Hydride Reductions01:17

Esters to Alcohols: Hydride Reductions

4.7K
Esters are reduced to primary alcohols when treated with a strong reducing agent like lithium aluminum hydride. The reaction requires two equivalents of the reducing agent and proceeds via an aldehyde intermediate.
Lithium aluminum hydride is a source of hydride ions and functions as a nucleophile. The mechanism proceeds in three steps. Firstly, the nucleophilic hydride ion attacks the carbonyl carbon of the ester to form a tetrahedral intermediate. Subsequently, the carbonyl group re-forms,...
4.7K
Alcohols from Carbonyl Compounds: Reduction02:23

Alcohols from Carbonyl Compounds: Reduction

12.2K
Reduction is a simple strategy to convert a carbonyl group to a hydroxyl group. The three major pathways to reduce carbonyls to alcohols are catalytic hydrogenation, hydride reduction, and borane reduction.
Catalytic hydrogenation is similar to the reduction of an alkene or alkyne by adding H2 across the pi bond in the presence of transition metal catalysts like Raney Ni, Pd–C, Pt, or Ru. Aldehydes and ketones can be reduced by this method, often under mild to moderate heat (25–100°C) and...
12.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer detection in the European Randomised Study of Screening for Prostate Cancer (ERSPC).

BJU international·2026
Same author

The PIECES multi-site comparative case study protocol: mixed methods implementation evaluation of adapting, implementing and tailoring primary cancer prevention programmes in diverse contexts.

Implementation science communications·2026
Same author

Recruitment strategies and outcomes in lung cancer screening programmes: a scoping review.

European radiology·2026
Same author

[Towards an organised programme for prostate cancer screening].

Epidemiologia e prevenzione·2026
Same author

Effectiveness of Lung Cancer Screening by Sex and Tumor Histology: Extended, Pooled Analysis of the ITALUNG and LUSI Trials, with Comparison to Findings in the NLST.

Cancer communications (London, England)·2026
Same author

A randomized controlled trial testing behavioral economics messages and screening choices to increase participation among previous non-attenders in florence's colorectal cancer screening program.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026

Related Experiment Video

Updated: Jan 23, 2026

Screening of Tobacco Genotypes for Phytophthora nicotianae Resistance
10:10

Screening of Tobacco Genotypes for Phytophthora nicotianae Resistance

Published on: April 15, 2022

4.1K

[Harm reduction strategy in tobacco control].

Giuseppe Gorini1

  • 1SC Epidemiologia ambientale occupazionale - ISPO, Firenze. g.gorini@ispo.toscana.it

Epidemiologia E Prevenzione
|September 20, 2011
PubMed
Summary

Potentially Reduced Exposure Products (PREPs) like low-nicotine cigarettes and snus are available, but their health effects are largely unknown. Regulation is needed to ensure accurate risk communication and protect public health.

Area of Science:

  • Public Health
  • Tobacco Control
  • Toxicology

Background:

  • Potentially Reduced Exposure Products (PREPs), including low-nitrosamine cigarettes and smokeless tobacco (e.g., Swedish Snus), are increasingly available.
  • Many PREPs, excluding snus and medicinal nicotine, lack comprehensive health effect studies despite marketing claims of reduced risk.
  • Past promotional strategies for 'light' cigarettes led to public health issues, highlighting the need for caution with new tobacco products.

Purpose of the Study:

  • To analyze the current landscape of Potentially Reduced Exposure Products (PREPs).
  • To evaluate the health risks and regulatory challenges associated with PREPs.
  • To examine different regulatory approaches to PREPs and medicinal nicotine.

Main Methods:

  • Review of existing literature on PREPs, including their composition and available health studies.

More Related Videos

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

Published on: May 10, 2016

12.7K
Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
09:25

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

11.8K

Related Experiment Videos

Last Updated: Jan 23, 2026

Screening of Tobacco Genotypes for Phytophthora nicotianae Resistance
10:10

Screening of Tobacco Genotypes for Phytophthora nicotianae Resistance

Published on: April 15, 2022

4.1K
High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

Published on: May 10, 2016

12.7K
Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
09:25

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

11.8K
  • Analysis of regulatory stances from international bodies (WHO) and national authorities (USA, UK).
  • Examination of proposed regulatory frameworks for balancing the nicotine market.

    • Main Results:

    • Only medicinal nicotine and snus show potential as PREPs, but still pose health risks.
    • The World Health Organization recommends mandated lowering of specific carcinogens and warns against promotional use of risk reduction.
    • Current regulations create disparities, limiting smokers' access to potentially safer nicotine alternatives.

    Conclusions:

    • A balanced regulatory approach is needed to manage the nicotine market, similar to proposals by the UK Royal College of Physicians.
    • Regulatory bodies like the FDA are tasked with evaluating PREPs and setting criteria for reduced toxicants.
    • The study raises questions about Italy's future approach to regulating PREPs and medicinal nicotine.